2026 Q3 Portfolio Activity
In 2026 Q3, JOHNSON & JOHNSON maintained a portfolio of 15 distinct positions. They heavily accumulated shares in CEREBRAS SYSTEMS INC, increasing the position by 140.1%.
Position History
hover any row below to update
Loading…
Total Positions
15
Quarter
2026 Q3
Top Holding
PTGX (45.3%)
Top 10 Concentration
98.8%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
Showing 1-15 of 15
JOHNSON & JOHNSON Full Holdings List — 2026 Q3
| Stock | History | Sector / Type | Port % | Prev % | Rank / Prev | Conviction | Change | % Change | Influence | Shares | Mkt Value | Avg Cost | Price Held | 1st Owned | Source | Source Date | Date Reported | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
PTGX
PROTAGONIST THE...
|
Healthcare | 45.30% | 37.59% |
#1
Prev: #1
|
7.0 |
—
|
no change | no change |
P
S
|
2,449,183 | $345,065,393 | 2021 Q3 | 13F Filing | 2026-09-30 | 2026-10-26 | |||
|
NBTX
NANOBIOTIX
|
Healthcare | 23.01% | 26.55% |
#2
Prev: #2
|
6.5 |
—
|
no change | no change |
P
S
|
5,623,816 | $175,238,107 | 2023 Q3 | 13F Filing | 2026-09-30 | 2026-10-26 | |||
|
MGTX
MEIRAGTX HLDGS ...
|
Healthcare | 9.59% | 11.23% |
#3
Prev: #3
|
5.8 |
—
|
no change | no change |
P
S
|
6,641,064 | $73,051,704 | 2021 Q3 | 13F Filing | 2026-09-30 | 2026-10-26 | |||
|
RAPP
RAPPORT THERAPE...
|
Healthcare | 7.87% | 9.31% |
#4
Prev: #4
|
4.6 |
—
|
no change | no change |
P
S
|
1,784,517 | $59,959,771 | 2024 Q2 | 13F Filing | 2026-09-30 | 2026-10-26 | |||
|
CTNM
CONTINEUM THERA...
|
Healthcare | 3.49% | 4.06% |
#5
Prev: #5
|
2.9 |
—
|
no change | no change |
P
S
|
1,979,173 | $26,560,502 | 2024 Q2 | 13F Filing | 2026-09-30 | 2026-10-26 | |||
|
CBRS
CEREBRAS SYSTEM...
|
Technology | 3.00% | 1.48% |
#6
3
Prev: #9
|
4.2 |
—
|
75,063 | 140.1% |
P
S
|
128,649 | $22,854,495 | 2026 Q2 | 13F Filing | 2026-09-30 | 2026-10-26 | |||
|
XNCR
XENCOR INC
|
Healthcare | 2.45% | 1.51% |
#7
1
Prev: #8
|
2.0 |
—
|
no change | no change |
P
S
|
748,062 | $18,664,147 | 2021 Q4 | 13F Filing | 2026-09-30 | 2026-10-26 | |||
|
LEGN
LEGEND BIOTECH ...
|
Healthcare | 2.13% | 2.95% |
#8
2
Prev: #6
|
1.9 |
—
|
no change | no change |
P
S
|
814,586 | $16,202,116 | 2021 Q3 | 13F Filing | 2026-09-30 | 2026-10-26 | |||
|
FATE
FATE THERAPEUTI...
|
Healthcare | 1.05% | 1.14% |
#9
1
Prev: #10
|
1.4 |
—
|
no change | no change |
P
S
|
3,379,064 | $8,008,382 | 2021 Q3 | 13F Filing | 2026-09-30 | 2026-10-26 | |||
|
CVRX
CVRX INC
|
Healthcare | 0.92% | 2.59% |
#10
3
Prev: #7
|
1.4 |
—
|
no change | no change |
P
S
|
4,024,861 | $7,043,507 | 2021 Q3 | 13F Filing | 2026-09-30 | 2026-10-26 | |||
|
PRCT
PROCEPT BIOROBO...
|
Healthcare | 0.86% | 1.01% |
#11
Prev: #11
|
1.3 |
—
|
no change | no change |
P
S
|
357,939 | $6,521,649 | 2021 Q3 | 13F Filing | 2026-09-30 | 2026-10-26 | |||
|
NMRA
NEUMORA THERAPE...
|
Healthcare | 0.14% | 0.39% |
#12
Prev: #12
|
1.1 |
—
|
no change | no change |
P
S
|
1,849,445 | $1,102,639 | 2023 Q3 | 13F Filing | 2026-09-30 | 2026-10-26 | |||
|
VOR
VOR BIOPHARMA I...
|
Healthcare | 0.13% | 0.12% |
#13
Prev: #13
|
1.1 |
—
|
no change | no change |
P
S
|
53,732 | $1,025,207 | 2021 Q3 | 13F Filing | 2026-09-30 | 2026-10-26 | |||
|
LAB
STANDARD BIOTOO...
|
Healthcare | 0.03% | 0.03% |
#14
Prev: #14
|
1.0 |
—
|
no change | no change |
P
S
|
311,967 | $231,043 | 2024 Q1 | 13F Filing | 2026-09-30 | 2026-10-26 | |||
|
ACET
ADICET BIO INC
|
Healthcare | 0.02% | 0.02% |
#15
Prev: #15
|
1.0 |
—
|
no change | no change |
P
S
|
22,779 | $162,642 | 2021 Q3 | 13F Filing | 2026-09-30 | 2026-10-26 |
Showing 1-15 of 15 holdings